NASDAQ:HSDT Helius Medical Technologies (HSDT) Stock Price, News & Analysis → Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (From Paradigm Press) (Ad) Free HSDT Stock Alerts $1.01 -0.05 (-4.72%) (As of 06/14/2024 ET) Add Compare Share Share Today's Range$1.00▼$1.0950-Day Range$1.02▼$6.2452-Week Range$1.00▼$13.43Volume117,227 shsAverage Volume154,697 shsMarket Capitalization$2.99 millionP/E RatioN/ADividend YieldN/APrice Target$24.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Get Helius Medical Technologies alerts: Email Address Helius Medical Technologies MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside2,276.0% Upside$24.00 Price TargetShort InterestHealthy3.60% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.43Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.35 out of 5 stars 3.5 Analyst's Opinion Consensus RatingHelius Medical Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageHelius Medical Technologies has received no research coverage in the past 90 days.Read more about Helius Medical Technologies' stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted3.60% of the outstanding shares of Helius Medical Technologies have been sold short.Short Interest Ratio / Days to CoverHelius Medical Technologies has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Helius Medical Technologies has recently increased by 58.63%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldHelius Medical Technologies does not currently pay a dividend.Dividend GrowthHelius Medical Technologies does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for HSDT. Previous Next 1.9 News and Social Media Coverage News SentimentHelius Medical Technologies has a news sentiment score of 0.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.89 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Helius Medical Technologies this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for HSDT on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Helius Medical Technologies to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Helius Medical Technologies insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 5.10% of the stock of Helius Medical Technologies is held by insiders.Percentage Held by InstitutionsOnly 18.63% of the stock of Helius Medical Technologies is held by institutions.Read more about Helius Medical Technologies' insider trading history. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Helius Medical Technologies is -0.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Helius Medical Technologies is -0.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHelius Medical Technologies has a P/B Ratio of 0.30. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Helius Medical Technologies' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Paradigm PressMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… About Helius Medical Technologies Stock (NASDAQ:HSDT)Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.Read More HSDT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HSDT Stock News HeadlinesMay 29, 2024 | finance.yahoo.comHelius Medical Technologies, Inc. Announces Third-Party Reimbursement for PoNS® from Major Insurance CarrierMay 24, 2024 | msn.comHelius Medical Technologies Showcases MS Therapy Progress at Annual MeetingMay 23, 2024 | finance.yahoo.comHelius Medical Technologies to Exhibit at 2024 CMSC Annual Meeting, Marking a Year of Achievements: Making PoNS More Available to People with MSMay 23, 2024 | globenewswire.comHelius Medical Technologies to Exhibit at 2024 CMSC Annual Meeting, Marking a Year of Achievements: Making PoNS More Available to People with MSMay 21, 2024 | msn.comHelius Medical's PoNS Device Gains Federal Supply Schedule ApprovalMay 20, 2024 | globenewswire.comHelius Medical Technologies, Inc. Announces PoNS® Is Now Available on the Veterans Affairs (VA) Federal Supply Schedule (FSS) and General Services Administration (GSA) Advantage ContractsMay 15, 2024 | msn.comHelius Medical Technologies Moves Closer to Medicare Reimbursement, Expands Stroke ProgramMay 14, 2024 | msn.comHelius Medical Technologies, Inc. (NASDAQ:HSDT) Q1 2024 Earnings Call TranscriptMay 14, 2024 | finance.yahoo.comQ1 2024 Helius Medical Technologies Inc Earnings CallMay 14, 2024 | finance.yahoo.comHelius Medical Technologies Inc (HSDT) Q1 2024 Earnings Call Transcript Highlights: Strategic ...May 13, 2024 | globenewswire.comHelius Medical Technologies, Inc. Reports First Quarter 2024 Financial ResultsMay 10, 2024 | financialpost.comHelius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024May 10, 2024 | globenewswire.comHelius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024May 9, 2024 | msn.comHelius Medical Technologies Awaits CMS Decision on Medicare Reimbursement Rates for Innovative DeviceMay 7, 2024 | msn.comHelius Medical Technologies raises $6.4M via equity offeringMay 6, 2024 | globenewswire.comHelius Medical Technologies, Inc. Announces Pricing of $6.4 Million Public OfferingMay 6, 2024 | finance.yahoo.comHelius Medical Technologies, Inc. Announces Preliminary CMS Payment Determination of Reimbursement for Portable Neuromodulation Stimulator (PoNS®)May 3, 2024 | msn.comWhy Is Helius Medical Technology (HSDT) Stock Up 47% Today?May 3, 2024 | investorplace.comWhy Is Helius Medical Technology (HSDT) Stock Up 47% Today?April 24, 2024 | globenewswire.comHelius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd CenterApril 21, 2024 | finance.yahoo.comHelius Medical Technologies, Inc. (HSDT)April 17, 2024 | wsj.comHelius Medical Technologies Inc.April 15, 2024 | msn.comHelius Medical files to sell Class A common stock, warrantsApril 6, 2024 | msn.comHelius Medical Technologies Partners with Lovell to Bring Innovative MS Treatment to VeteransApril 3, 2024 | msn.comWhy Is Nano-Cap Helius Medical Stock Trading Higher On Wednesday?See More Headlines Receive HSDT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Helius Medical Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/13/2024Today6/15/2024Next Earnings (Estimated)8/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryN/A Current SymbolNASDAQ:HSDT CUSIPN/A CIK1610853 Webheliusmedical.com Phone(877) 564-0008FaxN/AEmployees26Year Founded2014Price Target and Rating Average Stock Price Target$24.00 High Stock Price Target$24.00 Low Stock Price Target$24.00 Potential Upside/Downside+2,276.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($13.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,850,000.00 Net Margins-1,328.14% Pretax Margin-1,328.14% Return on Equity-297.49% Return on Assets-107.36% Debt Debt-to-Equity RatioN/A Current Ratio3.51 Quick Ratio3.26 Sales & Book Value Annual Sales$640,000.00 Price / Sales4.67 Cash FlowN/A Price / Cash FlowN/A Book Value$3.32 per share Price / Book0.30Miscellaneous Outstanding Shares2,960,000Free Float2,812,000Market Cap$2.99 million OptionableNot Optionable Beta1.58 Social Links 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Dane Carl Andreeff (Age 58)President, CEO & Director Comp: $469.17kDr. Antonella Favit-Van Pelt M.D. (Age 57)Ph.D., Chief Medical Officer Comp: $432.67kMr. Lawrence PiccianoSenior Vice President of Engineering, Quality & Regulatory AffairsKey CompetitorsStar EquityNASDAQ:STRRGigCapital5NYSE:GIABioSig TechnologiesNASDAQ:BSGMNexalin TechnologyNASDAQ:NXLNuwellisNASDAQ:NUWEView All CompetitorsInsidersDane AndreeffBought 5,000 shares on 12/14/2023Total: $40,500.00 ($8.10/share)Dane AndreeffBought 2,000 shares on 11/30/2023Total: $12,740.00 ($6.37/share)Dane AndreeffBought 5,000 shares on 8/30/2023Total: $38,200.00 ($7.64/share)Dane AndreeffBought 5,078 shares on 8/28/2023Total: $32,346.86 ($6.37/share)View All Insider Transactions HSDT Stock Analysis - Frequently Asked Questions Should I buy or sell Helius Medical Technologies stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Helius Medical Technologies in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" HSDT shares. View HSDT analyst ratings or view top-rated stocks. What is Helius Medical Technologies' stock price target for 2024? 1 brokerages have issued 12-month target prices for Helius Medical Technologies' stock. Their HSDT share price targets range from $24.00 to $24.00. On average, they predict the company's share price to reach $24.00 in the next year. This suggests a possible upside of 2,276.0% from the stock's current price. View analysts price targets for HSDT or view top-rated stocks among Wall Street analysts. How have HSDT shares performed in 2024? Helius Medical Technologies' stock was trading at $8.04 on January 1st, 2024. Since then, HSDT shares have decreased by 87.4% and is now trading at $1.0101. View the best growth stocks for 2024 here. Are investors shorting Helius Medical Technologies? Helius Medical Technologies saw a increase in short interest in the month of May. As of May 31st, there was short interest totaling 106,600 shares, an increase of 58.6% from the May 15th total of 67,200 shares. Based on an average daily trading volume, of 423,700 shares, the short-interest ratio is presently 0.3 days. View Helius Medical Technologies' Short Interest. When is Helius Medical Technologies' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 8th 2024. View our HSDT earnings forecast. How were Helius Medical Technologies' earnings last quarter? Helius Medical Technologies, Inc. (NASDAQ:HSDT) posted its earnings results on Monday, May, 13th. The company reported ($3.08) earnings per share for the quarter. The company had revenue of $0.14 million for the quarter. Helius Medical Technologies had a negative trailing twelve-month return on equity of 297.49% and a negative net margin of 1,328.14%. When did Helius Medical Technologies' stock split? Helius Medical Technologies shares reverse split on the morning of Thursday, August 17th 2023. The 1-50 reverse split was announced on Thursday, August 17th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, August 17th 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. How do I buy shares of Helius Medical Technologies? Shares of HSDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:HSDT) was last updated on 6/15/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredTiny, One-Half Inch Pellet the Key to INFINITE Energy?It’s a tiny, $1 billion company that holds the key to this power. And yet, it’s the largest company of its ...Eagle Publishing | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Helius Medical Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Helius Medical Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.